Author

John Goulis

Observed names: Goulis J, Goulis John, Goulis, J, J Goulis, J. GOULIS, J. Goulis, John G. Goulis

Institution: Aristotle University of Thessaloniki

Observed institutions: University of Bern, NHS Blood and Transplant, Royal Free London NHS Foundation Trust, Aristotle University of Thessaloniki, The Royal Free Hospital, Centre Hospitalier Universitaire de Toulouse, Papageorgiou General Hospital, Ippokrateio General Hospital of Thessaloniki, Jena University Hospital, Polyclinic General Hospital, Hippocration General Hospital, University College London, Medical University of Vienna

OpenAlex ID: A5088143086

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

2015 · George Papatheodoridis, George Dalekos, et al. · Journal of Hepatology · 583

Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage

1998 · John Goulis, Anastasios Armonis, et al. · Hepatology · 425

PDF

Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis

1999 · George V. Papatheodoridis, John Goulis, et al. · Hepatology · 325

PDF

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1999 · John Goulis, Gioacchino Leandro, et al. · The Lancet · 317

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

2017 · George V. Papatheodoridis, Ramazan Idilman, et al. · Hepatology · 306

Bacterial infection in the pathogenesis of variceal bleeding

1999 · John Goulis, David Patch, et al. · The Lancet · 286

A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis

2002 · D. Patch, C.A. Sabin, et al. · Gastroenterology · 229

PDF

An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B

2021 · Hwi Young Kim, Pietro Lampertico, et al. · Journal of Hepatology · 160

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

2014 · George V. Papatheodoridis, George N. Dalekos, et al. · Journal of Hepatology · 158

Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation

1999 · J Goulis, T N Chau, et al. · Gut · 147

PDF

Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection?

2008 · George V. Papatheodoridis, Emanuel K. Manesis, et al. · Hepatology · 131

PDF

Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population

2018 · George V. Papatheodoridis, Vana Sypsa, et al. · Journal of Hepatology · 112

Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review

2011 · Evangelos Cholongitas, John Goulis, et al. · Liver Transplantation · 112

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B

2020 · George V. Papatheodoridis, Vana Sypsa, et al. · Journal of Hepatology · 110

2020 · George V. Papatheodoridis, George N. Dalekos, et al. · Journal of Hepatology · 93

The Role of Different Immunosuppression in the Long-term Histological Outcome of Hcv Reinfection After Liver Transplantation for Hcv Cirrhosis

2001 · George V. Papatheodoridis, Susan Davies, et al. · Transplantation · 92

Low Serum Adiponectin Levels Are Predictive of Advanced Hepatic Fibrosis in Patients With NAFLD

2009 · Savvoula Savvidou, Prodromos Hytiroglou, et al. · Journal of Clinical Gastroenterology · 75

Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy

2013 · George Papatheodoridis, John Goulis, et al. · Journal of Hepatology · 64

Herb-induced hepatitis by Teucrium polium L.: report of two cases and review of the literature

2007 · Savvoula Savvidou, John Goulis, et al. · European Journal of Gastroenterology & Hepatology · 57

High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity

2007 · George V. Papatheodoridis, John Goulis, et al. · European Journal of Gastroenterology & Hepatology · 53

Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review

2010 · Evangelos Cholongitas, Emmanouel Tsochatzis, et al. · Transplant International · 52

Long‐term therapy with adefovir dipivoxil in hepatitis B e antigen‐negative patients developing resistance to lamivudine

2007 · S. MANOLAKOPOULOS, S. BETHANIS, et al. · Alimentary Pharmacology & Therapeutics · 51

Anti‐ SLA / LP alone or in combination with anti‐Ro52 and fine specificity of anti‐Ro52 antibodies in patients with autoimmune hepatitis

2014 · Kalliopi Zachou, Stella Gampeta, et al. · Liver International · 50

An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye

2006 · C. Triantos, J. Goulis, et al. · Endoscopy · 49

Serum/Ascites Albumin Gradient: Its Value as a Rational Approach to the Differential Diagnosis of Ascites

1996 · E. A. Akriviadis, D. Kapnias, et al. · Scandinavian Journal of Gastroenterology · 45

Works count: 94

Citation count: 4,477

H-index: 28

I10-index: 39